1. Home
  2. JCTC vs LYRA Comparison

JCTC vs LYRA Comparison

Compare JCTC & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCTC
  • LYRA
  • Stock Information
  • Founded
  • JCTC 1953
  • LYRA 2005
  • Country
  • JCTC United States
  • LYRA United States
  • Employees
  • JCTC N/A
  • LYRA N/A
  • Industry
  • JCTC
  • LYRA Medical/Dental Instruments
  • Sector
  • JCTC
  • LYRA Health Care
  • Exchange
  • JCTC NYSE
  • LYRA Nasdaq
  • Market Cap
  • JCTC 13.2M
  • LYRA 15.0M
  • IPO Year
  • JCTC 1996
  • LYRA 2020
  • Fundamental
  • Price
  • JCTC $3.53
  • LYRA $7.95
  • Analyst Decision
  • JCTC
  • LYRA Buy
  • Analyst Count
  • JCTC 0
  • LYRA 2
  • Target Price
  • JCTC N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • JCTC 14.4K
  • LYRA 104.9K
  • Earning Date
  • JCTC 07-14-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • JCTC N/A
  • LYRA N/A
  • EPS Growth
  • JCTC N/A
  • LYRA N/A
  • EPS
  • JCTC N/A
  • LYRA N/A
  • Revenue
  • JCTC $44,141,421.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • JCTC N/A
  • LYRA N/A
  • Revenue Next Year
  • JCTC N/A
  • LYRA $139.18
  • P/E Ratio
  • JCTC N/A
  • LYRA N/A
  • Revenue Growth
  • JCTC N/A
  • LYRA N/A
  • 52 Week Low
  • JCTC $3.26
  • LYRA $3.81
  • 52 Week High
  • JCTC $5.41
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • JCTC N/A
  • LYRA 42.42
  • Support Level
  • JCTC N/A
  • LYRA $8.11
  • Resistance Level
  • JCTC N/A
  • LYRA $8.56
  • Average True Range (ATR)
  • JCTC 0.00
  • LYRA 0.45
  • MACD
  • JCTC 0.00
  • LYRA -0.16
  • Stochastic Oscillator
  • JCTC 0.00
  • LYRA 24.62

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: